4//SEC Filing
Hinshaw William 4
Accession 0001104659-22-110047
CIK 0001633070other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 6:49 PM ET
Size
7.2 KB
Accession
0001104659-22-110047
Insider Transaction Report
Form 4
Hinshaw William
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-10-17+50,000→ 98,012 total - Sale
Common Stock
2022-10-19$1.56/sh−16,000$25,027→ 82,012 total
Footnotes (3)
- [F1]On September 29, 2020, the Reporting Person was granted 50,000 restricted stock units ("RSUs"), which vest upon satisfaction of certain performance criteria. On October 17, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such RSUs.
- [F2]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.52 to $1.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Axcella Health Inc.
CIK 0001633070
Entity typeother
Related Parties
1- filerCIK 0001774662
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 6:49 PM ET
- Size
- 7.2 KB